J Kusenda

Summary

Affiliation: Slovak Academy of Sciences
Country: Slovakia

Publications

  1. ncbi request reprint Quantitative identification of blood cell markers in human hematopoietic malignancies with diagnostic and prognostic significance
    J Kusenda
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia
    Neoplasma 55:381-6. 2008
  2. ncbi request reprint Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment
    J Kusenda
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 51:97-102. 2004
  3. ncbi request reprint P53 protein expression in human leukemia and lymphoma cells
    E Koníková
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 48:290-8. 2001
  4. ncbi request reprint The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 52:502-9. 2005
  5. ncbi request reprint Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, 83391 Bratislava, Slovak Republic
    Neoplasma 52:211-8. 2005
  6. ncbi request reprint Possible prognostic value of nucleolar morphology in pathologic cells of B-chronic lymphocytic leukemia
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 57:429-37. 2010
  7. ncbi request reprint Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 48:350-7. 2001
  8. ncbi request reprint Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study
    M Klobusicka
    Cancer Research Institute Slovak Academy of Sciences, Bratislava
    Neoplasma 48:489-95. 2001
  9. ncbi request reprint Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 50:408-15. 2003
  10. ncbi request reprint Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 49:387-93. 2002

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Quantitative identification of blood cell markers in human hematopoietic malignancies with diagnostic and prognostic significance
    J Kusenda
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia
    Neoplasma 55:381-6. 2008
    ..FI data constitute a very important component of the analysis of cells in hematopoietic malignancy; standardized approach to instrument quality control, interlaboratory comparability of FI measurement and quality assurance is required...
  2. ncbi request reprint Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment
    J Kusenda
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 51:97-102. 2004
    ..Quantitative analysis of some markers in B-CLL cells seems to offer valuable information concerning possible influence of some chemotherapeutics on antigen equipment of leukemic cells...
  3. ncbi request reprint P53 protein expression in human leukemia and lymphoma cells
    E Koníková
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 48:290-8. 2001
    ..Loss of the normal p53 function may be important in the genesis of some leukemias. Elucidation of the mechanisms of p53 inactivation needs some more study...
  4. ncbi request reprint The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 52:502-9. 2005
    ..Increased information on benign B-lymphocyte precursors, especially that of existence of the 3rd type hematogones could provide a basis for better discrimination of B-leukemia cells even in a very small amounts...
  5. ncbi request reprint Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, 83391 Bratislava, Slovak Republic
    Neoplasma 52:211-8. 2005
    ....
  6. ncbi request reprint Possible prognostic value of nucleolar morphology in pathologic cells of B-chronic lymphocytic leukemia
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 57:429-37. 2010
    ..The simplicity and utility of the nucleolar test as a possible prognostic parameter may help to identify the subset of patients with early B-CLL disease that will run a more progressive course...
  7. ncbi request reprint Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment
    O Babusikova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 48:350-7. 2001
    ....
  8. ncbi request reprint Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study
    M Klobusicka
    Cancer Research Institute Slovak Academy of Sciences, Bratislava
    Neoplasma 48:489-95. 2001
    ..Although our preliminary results need to be confirmed in a larger group of patients, immunocytochemical analysis of p53 and Bcl-2 proteins, indicators of cell alterations, may help to identify risk patients requiring intensive therapy...
  9. ncbi request reprint Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 50:408-15. 2003
    ..Larger studies are needed in order to consolidate these preliminary results and characterize the possible prognostic value of AgNOR in association with p53 and bcl-2 proteins expression...
  10. ncbi request reprint Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients
    M Klobusicka
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 49:387-93. 2002
    ..Thus it would be possible to confirm our expectation of a possible value of the simultaneous aberrant expression of bcl-2 and p53 as useful predictors of future aggressive behavior of B-CLL...
  11. ncbi request reprint Altered expression of p53 and MDM2 proteins in hematological malignancies
    E Koníková
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 50:31-40. 2003
    ..It appears, that MDM2 overexpression, which may be p53-dependent, or also p53-independent plays an important role in leukemogenesis and/or disease progression...